TAYLOR HALL: Open Payments
NPI 1558939991 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 14 payments from 11 companies in 2025. Trend: 2023 $378 · 2024 $145 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $16 |
| Tris Pharma Inc | 1 | $15 |
Products named: TRINTELLIX, Auvelity, REXULTI, SPRAVATO, APLENZIN, Jornay PM, CAPLYTA, Xelstrym.
Industry payments across KS — which companies pay providers there.
